Key facts
- It has raised $41.8M; the latest was Early Stage VC ($13.9M) in Jun 2025.
- Notable investors include HSG (Hong Kong), SND Ventures Group, Shenzhen Yifeng Investment Management Enterprise, Suzhou Innovation Investment Group, Xingzheng Innovation Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Suzhou MedEdge Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Suzhou MedEdge Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Suzhou MedEdge Medical
Developer of interventional and implantable medical devices intended to enhance peripheral vascular and tumor interventions. The company's medical devices, created through innovative research and production methods, feature domestically produced and controlled ePTFE for medical implants and other coated medical equipment products, enabling the healthcare industry to access advanced treatment methods for peripheral vascular diseases and tumor interventions.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2021
- Website
- meimedical.com/
- Ownership
- Privately Held (backing)
Suzhou MedEdge Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Suzhou MedEdge Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Suzhou MedEdge Medical in its N-PORT filings yet. We sweep new filings monthly.